P3 Health Partners Inc.
$8.99-2.4%YTD+193.2%1Y+11.0%
Mentions · last 7 days
0
Price updated 8m ago·X counts updated 8d ago
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $PIII, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Care Facilities sits in its cycle right now — and what that implies for $PIII.
Medical - Care Facilities
Labor costs — nursing and clinical staffing — are the largest operating lever; travel nurse normalization is improving but costs remain above pre-COVID levels. Volume recovery in elective procedures is the topline tailwind.
What this means for $PIII
Neutral — P3 Health Partners Inc; exposure to the industry macro driver is limited or indirect.
Top industry ETF
$IHFiShares U.S. Healthcare Providers ETF
+17.6%YTD
+21.9%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
-0.3How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
-108%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
-15.2%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
-223%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.0Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
185%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
50.6%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
-0.4Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Aug 10, 2026$-0.63$-1.89+66.7%
Q1 2026May 14, 2026$0.32$-4.85+106.6%
Q4 2025Mar 26, 2026$-23.02$-8.06-185.5%
Q3 2025Nov 14, 2025$-9.67$-5.29-82.7%
Next earningsThu, Nov 12·consensus EPS $-3.96
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q1 FY26$386.4M+3.5%7.6%2.1%$0.37$-27.5M
Q4 FY25$384.8M+3.8%100%-40.0%$-23.02$-25.5M
Q3 FY25$345.3M-4.7%-7.1%-12.8%$-9.67$-15.5M
Q2 FY25$355.8M-6.2%100%-9.6%$-6.23$-16.6M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$1.5B$1.5B – $1.5B-$8.45-$8.61 – -$8.281
FY27$1.6B$1.6B – $1.7B-$3.00-$7.32 – $1.332
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.9×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.50%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-13.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+48.3%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatTiny float · 1.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today2.7% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β1.645-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
SC 13D/AActivist amendmentAug 12SC 13D/A
AI summary
8-KMaterial agreementJul 68-K — Item 1.01: Material agreement
AI summary
8-KShareholder voteJun 108-K — Item 5.07: Shareholder vote
AI summary
8-KListing / delisting noticeMay 268-K — Item 3.01: Listing / delisting notice
AI summary
8-KListing / delisting noticeMay 158-K — Item 3.01: Listing / delisting notice · Item 8.01: Other event
AI summary
8-KMaterial agreementApr 288-K — Item 1.01: Material agreement · Item 3.02: Unregistered equity sale · Item 5.03: Charter amendment
AI summary
8-KMaterial agreementMar 258-K — Item 1.01: Material agreement
+ 10 other (3 earnings 8-Ks · 2 10-Qs · 2 proxys · 1 PRE 14A) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
More in Medical - Care Facilities
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · last 7 days
No standout posts about $PIII on X in the last 7 days.